ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: knee

Pediatric Cases Require Special Considerations & Aggressive Treatment Plans

Thomas R. Collins  |  March 12, 2020

ATLANTA—Managing pediatric patients with rheumatic disease involves special considerations, such as developmental concerns and physiological traits that may affect dosing of medications, according to two experts. During a session at the 2019 ACR/ARP Annual Meeting, Courtney Kremer, ARNP, a pediatric nurse practitioner at the University of Iowa Stead Family Children’s Hospital, Iowa City, and Jessica…

Filed under:Biologics/DMARDsConditionsMeeting ReportsPediatric Conditions Tagged with:2019 ACR/ARP Annual Meetingjuvenile idiopathic arthritis (JIA)

Thoughtful Pediatric Care: Pediatric Cases Require Special Considerations & Aggressive Treatment Plans

Thomas R. Collins  |  March 9, 2020

In Canada, five provinces will now reimburse patients with plaque psoriasis who use risankizumab. Also, Canada Health has approved apremilast for treating adults with plaque psoriasis and psoriatic arthritis…

Filed under:Conditions Tagged with:2019 ACR/ARP Annual Meetingpediatric arthritisPediatric RheumatologyPediatrics

Remembering Etanercept & the Advent of the Biologic Era

Robert S. Katz, MD  |  February 10, 2020

As a veteran rheumatologist, I remember the clinical trials of etanercept’s (Enbrel’s) efficacy. And when the drug was first approved in 1998, I participated in those clinical trials and realized the effectiveness was astonishing. It was easy to tell which patients were treated with etanercept vs. those who received placebo, even though both groups were…

Filed under:Biologics/DMARDsSpeak Out Rheum Tagged with:etanerceptSpeak Out Rheumatology

Case Report: Obliterative Bronchiolitis in Rheumatoid Arthritis

Robin Paudel, MD, Prerna Dogra, MD, & Richard S. Morehead, MD  |  January 17, 2020

A 59-year-old woman with rheuma­toid arthritis (RA) presented to our pulmonary clinic for progressively worsening dyspnea of five years’ duration. She described progressively worsening dyspnea after a few minutes of walking on level ground. In addition, she noted worsening pain and morning stiffness of the wrists, knees and metacarpophalangeal (MCP) joints, with subcutaneous nodules. She…

Filed under:ConditionsRheumatoid Arthritis Tagged with:bronchiolitisbronchorreacase reportdyspnea

Ethics Forum: 3 Ways to Resolve Conflict When Children Refuse Treatment

B. Anne Eberhard, MBBS, MSc, FRACP, FRCPC  |  January 17, 2020

In the middle of a busy clinic I go to see my next patient, a 16-year-old girl with a swollen knee. I had seen her the week before and, after discussing the options regarding treatment of her arthritis, had organized a joint injection for today. As I walk in the door she emphatically informs me,…

Filed under:Ethics Tagged with:arbitrationEthics ForumInformed ConsentPediatric Rheumatology

Tashatuvango / shutterstock.com

Myositis-Specific Antibodies Identified

Mithu Maheswaranathan, MD, & Lisa Criscione-Schreiber, MD, MEd  |  January 16, 2020

The idiopathic inflammatory myopathies (IIM) encompass eight categories: 1) dermatomyositis (DM) in adults, 2) juvenile dermatomyositis, 3) amyopathic DM, 4) cancer-associated DM, 5) polymyositis, 6) immune-mediated necrotizing myopathy, 7) inclusion body myositis, and 8) overlap myositis.1 These categories help classify the myopathies based on clinical and histologic features. The incidence of IIM is estimated at…

Filed under:ConditionsMyositis Tagged with:dermatomyositisidiopathic inflammatory myopathiesidiopathic inflammatory myositismyositis-specific antibodiespolymyositis

Immunoassay May Help Identify Pediatric Lyme Arthritis

Marilynn Larkin  |  December 18, 2019

NEW YORK (Reuters Health)—In Lyme disease-endemic areas, a C6 peptide enzyme immunoassay (EIA) test may help guide initial management of children with acute arthritis, an observational study suggests.1 “Children with Lyme disease frequently present to the emergency department with an inflamed joint,” Lise Nigrovic, MD, MPH, of Boston Children’s Hospital tells Reuters Health by email….

Filed under:Conditions Tagged with:assayC6 peptide enzyme immunoassay (EIA)Lyme arthritisLyme Disease

Coding Corner Questions: Rheumatology Word Search

From the College  |  December 18, 2019

Questions What type of drug is interchangeable with an FDA-approved biologic? What drug is used in conjunction with infliximab, unless the patient cannot tolerate it? What can be used as a key element in an evaluation and management (E/M) service, along with the history, exam and medical decision making? What drives the level of an…

Filed under:Billing/CodingFrom the College Tagged with:Evaluation and Managementinfliximab

My Experience at the 2019 Rheumatology Research Workshop: Opportunity to Meet Peers & Role Models

Jean Liew, MD  |  December 13, 2019

I had the opportunity to attend the Rheumatology Research Workshop in Washington, D.C., in June 2019. Held annually, this two-day meeting is run by the ACR Early Career Investigators (ECI) Subcommittee and is geared toward trainees at all levels (fellows, residents and medical students) and junior faculty with an interest in a rheumatology research career….

Filed under:Career DevelopmentProfessional Topics Tagged with:CareerEducationRheumatology Research Workshop

Make Rehab Fun: Virtual Reality & Therapeutic Gaming

Thomas R. Collins  |  December 12, 2019

Using virtual reality in rehabilitation can have benefits—as long as it is properly understood. In fact, some evidence suggests benefits from the judicious use of immersive virtual reality with patients with rheumatic diagnoses. People tend to have a lower perception of effort compared with actual exertion and lower reports of pain with longer time to exhaustion.

Filed under:Meeting ReportsTechnology Tagged with:2019 ACR/ARP Annual MeetingExercise/physical therapyoccpational therapy

  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 79
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences